Anixa Additional U.S. Patent for Ovarian Cancer Vaccine Tech

  Anixa Biosciences Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent Number 11,786,489, which broadens protection of Anixa's novel ovarian cancer vaccine technology. 

https://www.biospace.com/article/releases/anixa-biosciences-announces-issuance-of-additional-u-s-patent-for-ovarian-cancer-vaccine-technology/